Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127770471 | 12777047 | 1 | I | 20090709 | 20160216 | 20160923 | 20160923 | EXP | FR-TAKEDA-2016MPI001235 | TAKEDA | 59.00 | YR | F | Y | 0.00000 | 20160923 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127770471 | 12777047 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | U | 21602 | INJECTION | ||||||||
| 127770471 | 12777047 | 2 | SS | VELCADE | BORTEZOMIB | 1 | UNK | U | 21602 | INJECTION | |||||||||
| 127770471 | 12777047 | 3 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | U | 21602 | INJECTION | ||||||||
| 127770471 | 12777047 | 4 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | U | 21602 | INJECTION | ||||||||
| 127770471 | 12777047 | 5 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | U | 21602 | INJECTION | ||||||||
| 127770471 | 12777047 | 6 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | U | 21602 | INJECTION | ||||||||
| 127770471 | 12777047 | 7 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | U | 21602 | INJECTION | ||||||||
| 127770471 | 12777047 | 8 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | U | 21602 | INJECTION | ||||||||
| 127770471 | 12777047 | 9 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 127770471 | 12777047 | 10 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | UNK | U | 0 | ||||||||||
| 127770471 | 12777047 | 11 | SS | REVLIMID | LENALIDOMIDE | 1 | Unknown | 15 MG, 3/WEEK | N | 0 | 15 | MG | TIW | ||||||
| 127770471 | 12777047 | 12 | SS | THALIDOMIDE | THALIDOMIDE | 1 | Unknown | 100 MG, QD | U | 0 | 100 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127770471 | 12777047 | 1 | Plasma cell myeloma |
| 127770471 | 12777047 | 9 | Plasma cell myeloma |
| 127770471 | 12777047 | 11 | Plasma cell myeloma |
| 127770471 | 12777047 | 12 | Plasma cell myeloma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127770471 | 12777047 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127770471 | 12777047 | Haematotoxicity | |
| 127770471 | 12777047 | Pain | |
| 127770471 | 12777047 | Paraesthesia | |
| 127770471 | 12777047 | Renal failure | |
| 127770471 | 12777047 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 127770471 | 12777047 | 1 | 20090416 | 0 | ||
| 127770471 | 12777047 | 2 | 20090427 | 0 | ||
| 127770471 | 12777047 | 3 | 20090515 | 0 | ||
| 127770471 | 12777047 | 4 | 20090709 | 0 | ||
| 127770471 | 12777047 | 5 | 20090723 | 0 | ||
| 127770471 | 12777047 | 6 | 20090727 | 0 | ||
| 127770471 | 12777047 | 7 | 20090730 | 20090731 | 0 | |
| 127770471 | 12777047 | 8 | 20141113 | 201601 | 0 | |
| 127770471 | 12777047 | 9 | 20090416 | 0 | ||
| 127770471 | 12777047 | 10 | 20090730 | 20090731 | 0 | |
| 127770471 | 12777047 | 11 | 20110202 | 20110217 | 0 | |
| 127770471 | 12777047 | 12 | 20100324 | 0 |